2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$29.00-$0.04 (-0.12%)
Price as of Sep 11, 2026 7:59 PM EDT- $1.9BMarket Cap
- 23.74%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$29.00-$0.04 (-0.12%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.03 | ||
Change | -$0.31 (-1.06%) | ||
Open | $29.82 | ||
High | $30.16 | ||
Low | $29.01 | ||
Previous Close | $29.34 | ||
Volume | 600,715 | ||
30-Day Average Volume | 796,179 | ||
1-Week Change | -2.62% | ||
1-Month Change | -11.92% | ||
1-Year Change | 23.74% | ||
3-Year Change | 448.77% | ||
5-Year Change | 19.07% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $394.0M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $9.3M | ||
Net Income | -$61.6M | ||
Free Cash Flow | -$58.6M | ||
EBIT | -$61.6M | ||
EBITDA | -$61.1M | ||
Net Working Capital | $280.6M | ||
EPS | -$0.93 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 189 | ||
P/B | 5 | ||
P/E | -31 | ||
PEG | 2 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue